Skip to content
2000
Volume 16, Issue 3
  • ISSN: 2589-9775
  • E-ISSN:

Abstract

Peptides represent a class of natural molecules with diverse physiological functions, including hormone regulation, neurotransmission, and immune modulation. In recent years, peptide- based therapeutics have gained significant attention in pharmaceutical research and development due to their high specificity, efficacy, and relatively low toxicity. This review provides an overview of the current landscape of peptide drug development, highlighting the challenges faced in their formulation and delivery and the innovative strategies employed to overcome these hurdles. The review explores the wide range of applications of peptide drugs in treating various diseases, including HIV, multiple sclerosis, osteoporosis, chronic pain, diabetes, and cancer. Examples of FDA-approved peptide drugs and ongoing clinical trials are presented, showcasing the continuous advancements in peptide-based therapeutics across different therapeutic areas. This review underscores the promising potential of peptide drugs as targeted and effective treatments for a multitude of medical conditions, offering improved therapeutic outcomes and enhanced patient care.

Loading

Article metrics loading...

/content/journals/cdrr/10.2174/0125899775295960240406073630
2024-11-01
2024-10-15
Loading full text...

Full text loading...

/content/journals/cdrr/10.2174/0125899775295960240406073630
Loading
  • Article Type: Review Article
Keyword(s): cancer; diabetes; HIV; metabolic disorders; osteoporosis; Peptide drugs
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test